product detail:
- Description: TB500 (Thymosin β4, acetate) is a synthetic form of the naturally occurring Thymosin β4 peptide, investigated in preclinical research for effects on cell migration, angiogenesis, wound healing, tissue repair, and anti‑inflammatory pathways.
- Format: Sterile lyophilized powder, 5 mg per vial. Typical purity ≥95% by HPLC/MS (refer to lot Certificate of Analysis for exact values).
- Intended use: For in vitro and preclinical research only. Not for human or veterinary administration.
- Key applications: Cell migration and wound‑closure assays, angiogenesis and endothelial cell studies, tissue repair/explant models, fibrosis and inflammation research, and mechanistic studies of actin‑binding and cytoskeletal regulation.
- Reconstitution: Reconstitute under aseptic conditions using sterile bacteriostatic water or recommended vehicle to the required concentration. Record final concentration, filter if required by your protocol, and use within the validated post‑reconstitution stability window provided on the CoA.
- Storage & stability: Store lyophilized at 2–8 °C for short term; −20 °C or lower for long‑term storage. Protect from light and humidity. Avoid repeated freeze–thaw cycles. Consult batch CoA for expiry and stability after reconstitution.
- Quality & documentation: Supplied with batch‑specific Certificate of Analysis (purity, identity by MS, water content, endotoxin if tested), lot number, and SDS on request.
- Safety / regulatory: THIS PRODUCT IS INTENDED AS A RESEARCH CHEMICAL ONLY. Use only for in vitro testing and laboratory experimentation. Bodily introduction into humans or animals is strictly prohibited. Handle only by qualified personnel using appropriate PPE and containment. This product is not a drug, food, or cosmetic and must not be misbranded, misused, or mislabeled as such.